-+ 0.00%
-+ 0.00%
-+ 0.00%

BTIG Maintains Buy on LifeMD, Lowers Price Target to $9

Benzinga·08/06/2026 09:28:02
Listen to the news
BTIG analyst David Larsen maintains LifeMD (NASDAQ:LFMD) with a Buy and lowers the price target from $10 to $9.